Taipei, Taiwan

Ping-Shan Lai

This inventor holds 3 USPTO granted patents. Top assignee: Aihol Corporation. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ping-Shan Lai. Retrieved from https://idiyas.com/inventor/ping-shan-lai-l8m6cbhi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Ping-Shan Lai in Neurodegenerative Disease Treatment

Introduction

Ping-Shan Lai is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical science, particularly in the treatment of neurodegenerative diseases. With a total of 3 patents to his name, his work focuses on the development of hyaluronan conjugates.

Latest Patents

Among his latest patents, Ping-Shan Lai has developed innovative hyaluronan conjugates that include a hyaluronic acid (HA), a sex hormone, and a linker for coupling one of the disaccharide units of the HA and the sex hormone. These conjugates are specifically designed for use in treating neurodegenerative diseases. The methods disclosed in his patents highlight the potential of these conjugates in both treating and preventing such conditions.

Career Highlights

Ping-Shan Lai is associated with Aihol Corporation, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on healthcare and therapeutic applications.

Collaborations

Some of his notable coworkers include Szu-Yuan Lee and Chih-An Lin, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Ping-Shan Lai's innovative work in the field of hyaluronan conjugates represents a promising advancement in the treatment of neurodegenerative diseases. His contributions are paving the way for new therapeutic options in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…